IBRX

IBRX

USD

ImmunityBio Inc. Common Stock

$2.130+0.050 (2.404%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.080

Máximo

$2.140

Mínimo

$2.000

Volumen

0.82M

Fundamentos de la Empresa

Capitalización de Mercado

2.1B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

9.96M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $1.83Actual $2.130Máximo $5.88

Noticias Relacionadas

BusinessWire

Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024

Q3 2025 Revenue and Other Income Growth with Continued Strong Sales Momentum: $33.7 million of total revenue and other income, up from $26.4 million in Q2 2025. Product Revenue: Up 434% in Q3 2025 versus Q3 2024,

Ver más
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024